Singapore: Personalized medicine market will be worth over USD149 billion by 2020, growing at a CAGR of 8.74 percent, and will be driven by oncology, cardiovascular and infectious disease treatment and diagnostics market, according to a recent report.

The total personalized targeted therapeutic market, for all indications, will grow at a CAGR of 6.47 percent over the next five years. Strong vertical growth in the companion diagnostic segment however will see a CAGR of 23.71 percent to 2020, mainly coming from oncology, cardiovascular and infectious disease (HIV/HCV) tests. Advancing technologies within the liquid biopsy market is also driving the market and will see strategic growth over the next five years with a CAGR of 20.6 percent.